Compound 1505
Identifiers
- Canonical SMILES:
CC(C)CN(Cc1cc(Cl)cc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)S(=O)(=O)c1cccnc1
- IUPAC name:
N-[[3-chloro-5-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-(2-methylpropyl)pyridine-3-sulfonamide
- InChi:
InChI=1S/C27H32Cl3N3O5S2/c1-18(2)14-32(39(35,36)24-6-5-7-31-13-24)16-20-8-21(10-22(28)9-20)17-33(15-19(3)4)40(37,38)26-12-23(29)11-25(30)27(26)34/h5-13,18-19,34H,14-17H2,1-4H3
- InChiKey:
ULOPBORZMUGTSP-UHFFFAOYSA-N
External links
![]() 44594685 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 15 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 8.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 647.08 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 6.31 | |||
TPSA | 107.88 | |||
RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 15 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.00 | |
WO2009152082 | 15 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5817 | Evatanepag | DB12022 | |
0.5354 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.5087 | Taprenepag | DB12623 | |
0.5086 | CGS-27023 | DB07556 | |
0.4570 | (2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE | DB07568 | |
0.4551 | 5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide | DB08211 | |
0.4518 | Sulfabenzamide | DB09355 | |
0.4500 | 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | DB07996 | |
0.4494 | (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE | DB07876 | |
0.4477 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4463 | (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE | DB07583 | |
0.4460 | Fasudil | DB08162 | |
0.4439 | Avagacestat | DB11893 | |
0.4438 | ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE | DB07947 | |
0.4340 | Hydroxyfasudil | DB04707 |